COMPARISON OF PLASMA ANDROGEN GLUCURONIDE LEVELS AFTER PERCUTANEOUS OR PERORAL ANDROGEN TREATMENT IN MEN - EVIDENCE FOR IMPORTANT SPLANCHNIC CONTRIBUTION TO PLASMA 17-BETA-HYDROXYANDROGEN GLUCURONIDES

被引:17
作者
GIAGULLI, VA
VERDONCK, L
DESLYPERE, JP
GIORGINO, R
VERMEULEN, A
机构
[1] STATE UNIV GHENT HOSP, DEPT ENDOCRINOL, PINTELAAN 185, B-9000 GHENT, BELGIUM
[2] UNIV BARI, INST INTERNAL MED ENDOCRINOL & METAB DIS, I-70124 BARI, ITALY
关键词
D O I
10.1210/jc.76.2.429
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate whether glucuronides of 17beta-hydroxyandrogens are formed mainly in peripheral tissues or in splanchnic tissues, we compared androstanediol (AD) glucuronide (ADG) and dihydrotestosterone (DHT) glucuronide (DHTG) levels as well as the ratios of glucuronides over free steroids after transcutaneous DHT gel administration to levels and ratios found after oral administration of testosterone undecanoate. Whereas DHT and AD plasma levels were much higher after transcutaneous DHT gel administration, ADG and DHTG levels as well as glucuronide/free androgen ratios were an order of a magnitude higher after oral TU. This indicates that 17beta-hydroxyandrogen glucuronides cannot be considered specific metabolites of androgen target tissues and are formed to a large extent in the splanchnic circulation.
引用
收藏
页码:429 / 431
页数:3
相关论文
共 22 条
[1]   TRANSDERMAL TESTOSTERONE THERAPY IN THE TREATMENT OF MALE HYPOGONADISM [J].
AHMED, SR ;
BOUCHER, AE ;
MANNI, A ;
SANTEN, RJ ;
BARTHOLOMEW, M ;
DEMERS, LM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (03) :546-551
[2]  
BEHRE HM, 1990, TESTOSTERONE ACTION, P115
[3]   LEVELS OF PLASMA STEROID GLUCURONIDES IN INTACT AND CASTRATED MEN WITH PROSTATIC-CANCER [J].
BELANGER, A ;
BROCHU, M ;
CLICHE, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (05) :812-815
[4]  
BROCHU M, 1987, FERTIL STERIL, V48, P948
[5]   PHARMACOLOGY AND METABOLISM OF TESTOSTERONE UNDECANOATE (TU), A NEW ORALLY ACTIVE ANDROGEN [J].
COERT, A ;
GEELEN, J ;
VISSER, JD ;
VANDERVIES, J .
ACTA ENDOCRINOLOGICA, 1975, 79 (04) :789-800
[6]   RANDOMIZED CLINICAL-TRIAL OF TESTOSTERONE REPLACEMENT THERAPY IN HYPOGONADAL MEN [J].
CONWAY, AJ ;
BOYLAN, LM ;
HOWE, C ;
ROSS, G ;
HANDELSMAN, DJ .
INTERNATIONAL JOURNAL OF ANDROLOGY, 1988, 11 (04) :247-264
[7]   IS PLASMA 5-ALPHA-ANDROSTANE 3-ALPHA,17-BETA-DIOL GLUCURONIDE A BIOCHEMICAL MARKER OF HIRSUTISM IN WOMEN [J].
GIAGULLI, VA ;
GIORGINO, R ;
VERMEULEN, A .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1991, 39 (01) :55-61
[8]   PRECURSORS OF PLASMA ANDROSTANEDIOL-GLUCURONIDES AND ANDROGEN-GLUCURONIDES IN WOMEN [J].
GIAGULLI, VA ;
VERDONCK, L ;
GIORGINO, R ;
VERMEULEN, A .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1989, 33 (05) :935-940
[9]   LYMPHATIC ABSORPTION AND METABOLISM OF ORALLY-ADMINISTERED TESTOSTERONE UNDECANOATE IN MAN [J].
HORST, HJ ;
HOLTJE, WJ ;
DENNIS, M ;
COERT, A ;
GEELEN, J ;
VOIGT, KD .
KLINISCHE WOCHENSCHRIFT, 1976, 54 (18) :875-&
[10]   3-ALPHA, 17-BETA-ANDROSTANEDIOL GLUCURONIDE IN PLASMA - A MARKER OF ANDROGEN ACTION IN IDIOPATHIC HIRSUTISM [J].
HORTON, R ;
HAWKS, D ;
LOBO, R .
JOURNAL OF CLINICAL INVESTIGATION, 1982, 69 (05) :1203-1206